Therapeutic delivery

Using Tiny Particles for Combined Diagnosis and Treatment in Personalized Cancer Care

Updated

Abstract

Generalized nanoparticle platforms have reached Phase II/III trials, but truly patient-specific nanotheranostic systems remain largely at early clinical stages.

  • Nanotheranostics integrates cancer diagnosis and treatment within multifunctional nanosystems.
  • Current approaches are primarily technology-driven rather than tailored to individual patients.
  • AI could enhance the design of nanoplatforms by aligning them with patient-specific molecular profiles.
  • The review highlights barriers to clinical implementation, including biological, manufacturing, regulatory, and ethical challenges.
  • Emerging diagnostic techniques include SERS-based nanoprobes and circulating tumor DNA detection.
  • Therapeutic strategies discussed involve stimuli-responsive drug delivery, CRISPR-Cas9 nanodelivery, and personalized nanovaccines.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free